Thursday , 15 November 2018

EMGALITY: TREATMENT OF MIGRAINE IN ADULTS

Emgality is used in preventive treatment of migraine in adults. It contain active ingredient was Galcanezumab-GNLM. Strength of copiktra was 120 mg/ml injectable.It is approved by an FDA 27/09/2018. For more details click here.

Scroll To Top